LOAN AND SECURITY AGREEMENT Dated as of January 7, 2015 between NOVOCURE LIMITED (as Borrower), and BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP (as Lender)Loan and Security Agreement • June 24th, 2015 • Novocure LTD • Surgical & medical instruments & apparatus • New York
Note Register; Ownership of Note. The ownership of an interest in this Note shall be registered on a record of ownership maintained by Lender. Notwithstanding anything else in this Note to the contrary, the right to the principal of, and stated interest on, this Note may be transferred only if the transfer is registered on such record of ownership and the transferee is identified as the owner of an interest in the obligation. Borrower shall be entitled to treat the registered holder of this Note (as recorded on such record of ownership) as the owner in fact thereof for all purposes and shall not be bound to recognize any equitable or other claim to or interest in this Note on the part of any other person or entity.
December 23, 2011Release Agreement • June 24th, 2015 • Novocure LTD • Surgical & medical instruments & apparatus • New York
TENTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 24th, 2015 • Novocure LTD • Surgical & medical instruments & apparatus • New York
This TENTH AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT is made as of June 1, 2015 (this “Agreement”), by and among (1) NovoCure Limited (the “Company”), a company incorporated under the Companies (Jersey) Law, 1991, as amended, (2) each Person listed under the heading “Qualified Shareholders” on Schedule A hereto, (3) each Person listed under the heading “Series A Investors” on Schedule A hereto (collectively, the “Series A Investors”), (4) each Person listed under the heading “Series B Investors” on Schedule A hereto (collectively, the “Series B Investors”), (5) each Person listed under the heading “Series C Investors” on Schedule A hereto (collectively, the “Series C Investors”), (6) each Person listed under the heading “Series D Investors” on Schedule A hereto (collectively, the “Series D Investors”), (7) each Person listed under the heading “Series E Investors” on Schedule A hereto (collectively, the “Series E Investors”), (8) each Person listed under the heading “Series F I
ELEVENTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENTInvestors Rights Agreement • June 24th, 2015 • Novocure LTD • Surgical & medical instruments & apparatus • New York
CONSULTING SERVICES AGREEMENTConsulting Services Agreement • June 24th, 2015 • Novocure LTD • Surgical & medical instruments & apparatus • New York
This CONSULTING SERVICES AGREEMENT is made as of the 24th day of June, 2014, by and between NovoCure Limited, a corporation with a principal place of business at, Le Masurier House, La Rue Le Masurier, St. Helier, JE2 4YE Jersey (the “Company”), and William F. Doyle, with a principal place of business located at c/o WFD Ventures, 1500 Broadway, 29th Floor, New York, NY 10036 (“Consultant”).
EMPLOYMENT AGREEMENTConfidential Treatment Requested • June 24th, 2015 • Novocure LTD • Surgical & medical instruments & apparatus
THIS AGREEMENT (the “Agreement”) is made and entered into as of this 2nd day of June 2002, by and between NovoCure Ltd. of Topaz Building, Sha’ar Ha’carmel, Matam, P.O.B 15022, Haifa, (the “Company”), and Eilon Kirson of XXXXX (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 24th, 2015 • Novocure LTD • Surgical & medical instruments & apparatus • New York
or to such other address as a Party may notify the other pursuant to a notice given in accordance with this Section 8(a). Any notice personally delivered shall be deemed received when given, or if given by facsimile or overnight courier shall be deemed received on the next business day and any notice mailed shall be deemed received on the third business day thereafter.
CONSULTING AGREEMENTConsulting Agreement • June 24th, 2015 • Novocure LTD • Surgical & medical instruments & apparatus
This Consulting Agreement is made and entered into as of this 1st day of May 2002, by and between Palti Consultants Ltd., a private Israeli company, with its principal offices at 51 Ruth St. Haifa Israel (“Consultant”), and Novo Cure Ltd., an Israeli corporation (“Company”).
STRATEGIC SUPPLIER AGREEMENTStrategic Supplier Agreement • June 24th, 2015 • Novocure LTD • Surgical & medical instruments & apparatus • New York
WHEREAS, as of October 31, 2011, ITT Corporation transferred to Exelis Inc. (“Exelis”) all the assets of ITT Corporation’s Defense & Information Solutions business segment, including its Electronic Systems Division, by virtue of a Distribution Agreement, dated October 25, 2011, between ITT Corporation and Exelis;
EMPLOYMENT AGREEMENTEmployment Agreement • June 24th, 2015 • Novocure LTD • Surgical & medical instruments & apparatus
This Agreement is entered into in Tel-Aviv, Israel on October 1, 2002 (hereinafter the “Effective Date”), by and between NovoCure Ltd. (the “Company”) and Asaf Danziger (the “Executive”).
